TrialNature medicine2025

Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial.

Karola S Jering et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.